|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/569 | (2006.01) |
| A61K 39/00 | (2006.01) | ||
| C12Q 1/68 | (2018.01) | ||
| G01N 33/68 | (2006.01) |
| (11) | Patento numeris | 3194970 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15772084.8 |
| Europos patento paraiškos padavimo data | 2015-09-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-07-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/049491 |
| Data | 2015-09-10 |
| (87) | Numeris | WO 2016/040682 |
| Data | 2016-03-17 |
| (30) | Numeris | Data | Šalis |
| 201462048742 P | 2014-09-10 | US |
| (72) |
DELAMARRE, Lelia , US
LUPARDUS, Patrick , US
MELLMAN, Ira , US
YADAV, Mahesh , US
JHUNJHUNWALA, Suchit , US
LILL, Jennie , US
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | IMMUNOGENIC MUTANT PEPTIDE SCREENING PLATFORM |
| IMMUNOGENIC MUTANT PEPTIDE SCREENING PLATFORM |